Your SlideShare is downloading. ×
Chronic Disease Epidemic – the Figures for Diabetes
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Chronic Disease Epidemic – the Figures for Diabetes


Published on

Chronic Disease Epidemic – the Figures for Diabetes. Pieber T. eHealth week 2010 (Barcelona: CCIB Convention Centre; 2010)

Chronic Disease Epidemic – the Figures for Diabetes. Pieber T. eHealth week 2010 (Barcelona: CCIB Convention Centre; 2010)

Published in: Health & Medicine

  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Chronic Disease Epidemic – The Figures for Diabetes Thomas R. Pieber Medical University of Graz Austria
  • 2. Conflict of Interest • The invited speaker has or had research co- operations with companies producing glucose lowering drugs or other diabetes related products. • Furthermore, the invited speaker was or is consultant or speaker at meetings for companies producing glucose lowering drugs, in many cases a honorarium as or is paid.
  • 3. Diabetes mellitus – a global burden • Defined by elevated blood glucose • Fasting: ≥7.0 mmol/l (126 mg/dl) • Postprandial or after glucose load: ≥11.1 mmol/l (200mg/dl) • Typical, but non-specific symptoms including thirst, increased urine volume, exhaustion, impaired wound healing, itching • Type 1 diabetes (~10%) – type 2 diabetes (~90%) • Chronic disease without cure • Increasing incidences • Burden of late complications
  • 4. Diabetes mellitus type 1 • Autoimmune disease leading to absolute insulin deficiency • Genetic factors • Environment • Increasing incidence, doubling of new cases in 2020-2025 • Shift to younger children Harjutsalo, 2008 • Shift to ‘low-risk’ groups Patterson, 2009
  • 5. Diabetes mellitus type 2 • Impaired insulin action and insulin secretion • Genetic factors • Age • Obesity • Sedentary life style • EU: prevalence of 6-10% • Increase in all age groups (including children) • Epidemics of obesity leads to epidemics of type 2 diabetes (380 Mio in 2025)
  • 6. Diabetes mellitus – microvascular complications • Caused by hyperglycaemia • Diabetic nephropathy • Diabetes is the leading cause for kidney replacement therapy • DNP can be prevented • Progression of DNP can be halted • Diabetic retinopathy • Diabetes is the leading cause for blindness in adults • DRP can be prevented • Progression of DRP can be halted
  • 7. Diabetes mellitus – macrovascular complications • Caused by diabetes-associated risk factors (hypertension, dyslipidaemia, hyperglycaemia, microvascular complications) • Diabetes is associated with 2-4x risk of myocardial infarction, heart failure, and stroke • Increased mortality • Prevention and adequate treatment
  • 8. Diabetes mellitus – diabetic foot syndrome • Caused by diabetic neuropathy, vascular disease and inadequate medical management • Diabetes is the leading cause for amputations of the lower limb (10-20x) • Increased mortality • DFS can be prevented • Progression of DFS can be halted
  • 9. “The Diabetes Paradoxon” • Diabetes is a complex chronic disease associated with devastating late complications • Dramatic increase in prevalence • Diabetes associated late complications could be prevented or reduced • Diabetes is an expensive disease • Health care systems fail to provide adequate care for citizens with diabetes
  • 10. “The Diabetes Paradoxon” • Health care system • Interfaces between caregivers not defined • Roles of caregivers not defined, referrals are not organised • Conflict of interest between different providers • Quality of care • Missing or insufficient documentation • Inadequate knowledge or implementation of evidence • Diabetic patient • Lack of patient education • Lack of empowerment
  • 11. Disease Management Programme • Approach to patient care that emphasizes coordinated, comprehensive care along the continuum of disease and across health care delivery systems • Views patients as entities experiencing the clinical course of a disease Ellrodt et al., JAMA 1997;278(20):1687-1692 Hunter/Fairfield, BMJ 1997;315:50-53
  • 12. What’s inside a DMP? (I) Quality Improvement Strategies DMAA recommendations for Disease Management • Population identification process • Evidence-based practice guidelines • Collaborative practice model to include physician and support- service providers • Risk identification and matching of interventions with need • Patient self-management education • Process and outcomes measurement, evaluation and management • Routine reporting/feedback loop • Appropriate use of information technology Disease Management Association of America (DMAA), 2002
  • 13. What’s inside a DMP? (II) Quality Improvement Strategies Classification of Strategies according to Cochrane EPOC (Effective Practice and Organization of Care) Group • Audit and Feedback • Case Management • Team Changes • Electronic Patient Registry • Clinician Reminders • Clinician Education • Facilitated Relay of Clinical Information to Clinicians • Patient Education • Promotion of Self-Management • Patient Reminder Systems • Continuous Quality Improvement Cochrane EPOC Group, 2001
  • 14. Disease Management Programme - Components Population Identification Patient Evidence Based Empowerment Care Pathways Collaborative practice model Clinician Education Reporting & and Training Feedback loop Evaluation Process Organization, Documentation, Communication Quality Management Information Systems
  • 15. Evidence Based Clinical Care Pathways and Education Initiative 15
  • 16. Disease Management Programme – The Evidence The Cochrane EPOC Group – Effect on HbA1c Shojania, 2006
  • 17. Chronic Disease Epidemic – the Figures for Diabetes … care along the continuum of disease … • Increasing prevalence for type 1 and type 2 diabetes • Doubling in the next 10 – 15 years • Pathophysiology only partly understood • Substantial impact on health care systems in the world • Prevention programmes are urgently needed
  • 18. Diabetes Prevention Programme • Identification of genetic and environmental factors leading to diabetes • Identification of pathophysiological pathways • Identification of effective prevention measures in randomized controlled trials • Identification of measures for population wide implementation • Evaluation and cost effectiveness
  • 19. Conclusions • Diabetes is a complex chronic disease with devastating late complications • Increasing prevalence (type 1 and type 2 diabetes) • Late complications can be prevented or reduced • Diabetes is an expensive disease • Disease Management Programmes may help to overcome major deficits in care • Diabetes prevention is of major importance for European health care systems